Merck & Co. 8-K
Leadership change
Douglas M. Baker Jr. succeeds Thomas H. Glocer as independent lead director Jan. 1, 2027, ahead of Glocer’s May 2027 board retirement.
Filed 2026-11-18 16:27 ET
- 5.02 Officer/director change
- 9.01 Financial Statements and Exhibits
Summary
Merck board leadership transition. Thomas H. Glocer will retire from the Board at the May 2027 annual meeting, and Douglas M. Baker, Jr., a director since 2022, will become independent lead director on 1/1/2027, succeeding Glocer.
Get emails when companies you follow file: email digest settings.
The summary is written by an AI model reading the filing.
Model 005 · prompt v192 · 2026-11-18 23:34:39Z